The program

	Wednesday 14 May, 2025
08.30 - 09.00	Registration and welcome
09.00 - 09.15	Introducing the research theme Early Detection (Marjanka Schmidt, NKI)
09.15 - 09.50	Keynote - Cancer screening; what about prostate cancer (Monique Roobol, ErasmusMC)
09.50 - 10.30	Biomarkers and risk stratification (part I)
	- DCIS overdiagnosis: a call for precision (Jelle Wesseling, NKI) - Risk-based breast cancer screening: from equality to equity (Mireille Broeders, RadboudUMC)
10.30 - 11.00	Coffee break
11.00 - 12.00	Biomarkers and risk stratification (part II)
	- Advancing detection and risk stratification of HPV-driven precancer lesions through DNA methylation biomarkers (Renske Steenbergen, AmsterdamUMC) - A less-is-more strategy in surveillance of Barrett’s esophagus in the Netherlands (Jacques Bergman, AmsterdamUMC) - Separating pussycats and tigers: Risk stratification of prostate cancer using infrared imaging (Peter Gardner, University of Manchester)
12.00 - 12.35	Lightning talks
12.35 - 13.35	Lunch break
13.35 - 15.55	Population approaches
	- The future of cervical cancer screening: methodological perspectives (Hans Berkhof, AmsterdamUMC) - The role of HTA analysis in early cancer detection (Esther Toes-Zoutendijk, ErasmusMC) - Prevention of CRC in Lynch syndrome (Monique van Leerdam, AVL) - Population screening: present and future visions (Sandra van Dijk, RIVM)
15.55 - 16.25	Coffee break
16.25 - 17.25	Artificial intelligence
	- Early diagnosis of cancer; the power of routine care data from general practice (Kristel van Asselt, UMCU) - AI in healthcare: from innovation towards impact (Joost Huiskens, Microsoft)
17.25 - 17.30	Closing remarks
17.30 - 18.30	Networking drinks
18.30 onwards	Dinner (optional)

	Thursday 15 May, 2025
08.30 - 09.00	Registration and welcome
09.00 - 09.15	Introducing the Center for Early Cancer Detection (Theo Ruers, NKI CECD)
09.15 - 09.50	Keynote - The future of cancer early detection research; a UK perspective (David Crosby, CRUK)
	The future of imaging, liquid biopsies and AI implementation in clinical settings: a critical note
09.50 - 10.50	Innovations in diagnostic technologies (part I)
	- Developing early detection biomarkers for renal cancer: pitfalls & challenges (Kim Smits, Maastricht University) - AI-Driven MRI for Early Detection of prostate cancer (Derya Yakar, UMCG) - The Ultrasound Revolution: Ultra-Fast and Super-Simple (Chris de Korte, RadboudUMC)
10.50 - 11.20	Coffee break
11.20 - 12.40	Innovations in diagnostic technologies (part II)
	- Lab-on-a-chip technologies for early cancer detection (Loes Segerink, University of Twente) - Spectroscopic liquid biopsies for the earlier detection of cancer (David Palmer, Dxcover) - A systems approach to cancer early detection (Gerrit Meijer, NKI) - What will be the role today of multi-cancer early detection tests? (David Weinberg, Fox Chase Cancer Center)
13.15 - 14.40	Lunch break
	- Invited focused session KWF (13.40 - 14.40) - Focused session: Implementing multi cancer early detection: transforming care or challenging the system? (Inspire2Live -13.40-14.40) - Networking opportunities
14.40 - 15.40	Early detection: prevention and implementation (part I)
	- Evidence for lung cancer screening in Europe (including 4ITLR) (Harry de Koning, ErasmusMC) - The potential of reducing cancer patient referral time in primary care (Sjoerd Elias, UMCU)
15.40 - 16.10	Coffee break
16.10 - 17.10	Early detection: prevention and implementation (part II)
	- It’s in the family (Caroline Willems, Stichting Erfelijke Kanker Nederland) - Cancer screening: The earlier, the better? Positive aspects and critical remarks (Carin Louis, NFK) - Cancer prevention: current evidence and guidance (Matty Weijenberg, Maastricht University)
17.10 - 17.20	Closing remarks

Download the program